![Bilal Arif](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bilal Arif
Direttore operativo presso
KALVISTA PHARMA
Patrimonio netto: 293 497 $ in data 31/05/2026
Profilo
Bilal Arif currently works at KalVista Pharmaceuticals, Inc., as Chief Operating Officer from 2025.
Mr. Arif also formerly worked at Sarepta Therapeutics, Inc., as Chief Technical Operations Officer & Executive VP from 2022 to 2025, Momenta Pharmaceuticals, Inc., as Vice President-Technical Operations from 2017 to 2019, and Shire Plc, as Vice President-Technical Operations from 2015 to 2017.
Mr. Arif received his undergraduate degree from McGill University, graduate degree from Tufts University, Masters Business Admin degree from Instituto de Empresa SL, and undergraduate degree from Western New England University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/08/2025 | 16.424 ( 0,02% ) | 293 497 $ | 31/05/2026 |
Posizioni attive di Bilal Arif
| Società | Posizione | Inizio |
|---|---|---|
| KALVISTA PHARMA | Direttore operativo | 06/10/2025 |
Precedenti posizioni note di Bilal Arif
| Società | Posizione | Fine |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 12/08/2025 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2019 |
| SHIRE | Direttore Tecnico/Scientifico/R&S | 01/03/2017 |
Formazione di Bilal Arif
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western New England University
 Western New England University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Empresa SL
 Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
